Literature DB >> 18276779

CD163, a marker of perivascular macrophages, is up-regulated by microglia in simian immunodeficiency virus encephalitis after haptoglobin-hemoglobin complex stimulation and is suggestive of breakdown of the blood-brain barrier.

Juan T Borda1, Xavier Alvarez, Mahesh Mohan, Atsuhiko Hasegawa, Andrea Bernardino, Sherrie Jean, Pyone Aye, Andrew A Lackner.   

Abstract

Macrophages and microglia are the major cell types infected by human immunodeficiency virus and simian immunodeficiency virus (SIV) in the central nervous system. Microglia are likely infected in vivo, but evidence of widespread productive infection (ie, presence of viral RNA and protein) is lacking. This conclusion is controversial because, unlike lymphocytes, macrophages and microglia cannot be discreetly immunophenotyped. Of particular interest in the search for additional monocyte/macrophage-lineage cell markers is CD163; this receptor for haptoglobin-hemoglobin (Hp-Hb) complex, which forms in plasma following erythrolysis, is expressed exclusively on cells of monocyte/macrophage lineage. We examined CD163 expression in vitro and in vivo by multiple techniques and at varying times after SIV infection in macaques with or without encephalitis. In normal and acutely SIV-infected animals, and in SIV-infected animals without encephalitis, CD163 expression was detected in cells of monocyte/macrophage lineage, including perivascular macrophages, but not in parenchymal microglia. However, in chronically infected animals with encephalitis, CD163 expression was detected in activated microglia surrounding SIV encephalitis lesions in the presence of Hp-Hb complex, suggesting leakage of the blood-brain barrier. CD163 expression was also induced on microglia in vitro after stimulation with Hp-Hb complex. We conclude that CD163 is a selective marker of perivascular macrophages in normal macaques and during the early phases of SIV infection; however, later in infection in animals with encephalitis, CD163 is also expressed by microglia, which are probably activated as a result of vascular compromise.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18276779      PMCID: PMC2258269          DOI: 10.2353/ajpath.2008.070848

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  62 in total

Review 1.  Reactive microgliosis.

Authors:  W J Streit; S A Walter; N A Pennell
Journal:  Prog Neurobiol       Date:  1999-04       Impact factor: 11.685

2.  Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis.

Authors:  L M Dallasta; L A Pisarov; J E Esplen; J V Werley; A V Moses; J A Nelson; C L Achim
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 3.  Haemoglobin scavenger receptor: function in relation to disease.

Authors:  Jolanta Zuwała-Jagiełło
Journal:  Acta Biochim Pol       Date:  2006-06-12       Impact factor: 2.149

4.  Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163).

Authors:  P Högger; J Dreier; A Droste; F Buck; C Sorg
Journal:  J Immunol       Date:  1998-08-15       Impact factor: 5.422

5.  Upregulation of microglia in drug users with and without pre-symptomatic HIV infection.

Authors:  G S Tomlinson; P Simmonds; A Busuttil; A Chiswick; J E Bell
Journal:  Neuropathol Appl Neurobiol       Date:  1999-10       Impact factor: 8.090

6.  Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection.

Authors:  R S Veazey; M DeMaria; L V Chalifoux; D E Shvetz; D R Pauley; H L Knight; M Rosenzweig; R P Johnson; R C Desrosiers; A A Lackner
Journal:  Science       Date:  1998-04-17       Impact factor: 47.728

7.  Microarray analysis of activated mixed glial (microglia) and monocyte-derived macrophage gene expression.

Authors:  Andrew V Albright; Francisco González-Scarano
Journal:  J Neuroimmunol       Date:  2004-12       Impact factor: 3.478

8.  Cell tropism of simian immunodeficiency virus in culture is not predictive of in vivo tropism or pathogenesis.

Authors:  Juan T Borda; Xavier Alvarez; Ivanela Kondova; Pyone Aye; Meredith A Simon; Ronald C Desrosiers; Andrew A Lackner
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

9.  Molecular characterization of the haptoglobin.hemoglobin receptor CD163. Ligand binding properties of the scavenger receptor cysteine-rich domain region.

Authors:  Mette Madsen; Holger J Møller; Marianne Jensby Nielsen; Christian Jacobsen; Jonas H Graversen; Timo van den Berg; Søren K Moestrup
Journal:  J Biol Chem       Date:  2004-09-24       Impact factor: 5.157

Review 10.  SIV infection of macaques--modeling the progression to AIDS dementia.

Authors:  M C Zink; J P Spelman; R B Robinson; J E Clements
Journal:  J Neurovirol       Date:  1998-06       Impact factor: 2.643

View more
  63 in total

Review 1.  Monocyte mobilization, activation markers, and unique macrophage populations in the brain: observations from SIV infected monkeys are informative with regard to pathogenic mechanisms of HIV infection in humans.

Authors:  Kenneth Williams; Tricia H Burdo
Journal:  J Neuroimmune Pharmacol       Date:  2011-12-14       Impact factor: 4.147

2.  Persistent accumulation of gut macrophages with impaired phagocytic function correlates with SIV disease progression in macaques.

Authors:  Zachary D Swan; Anthea L Bouwer; Elizabeth R Wonderlich; Simon M Barratt-Boyes
Journal:  Eur J Immunol       Date:  2017-07-24       Impact factor: 5.532

3.  Neurokinin-1 receptor (NK1-R) expression in the brains of SIV-infected rhesus macaques: implications for substance P in NK1-R immune cell trafficking into the CNS.

Authors:  Heather Vinet-Oliphant; Xavier Alvarez; Elizabeth Buza; Juan T Borda; Mahesh Mohan; Pyone P Aye; Florin Tuluc; Steven D Douglas; Andrew A Lackner
Journal:  Am J Pathol       Date:  2010-07-29       Impact factor: 4.307

Review 4.  Translating the brain transcriptome in neuroAIDS: from non-human primates to humans.

Authors:  Jessica M Winkler; Amrita Datta Chaudhuri; Howard S Fox
Journal:  J Neuroimmune Pharmacol       Date:  2012-02-28       Impact factor: 4.147

5.  Impact of short-term combined antiretroviral therapy on brain virus burden in simian immunodeficiency virus-infected and CD8+ lymphocyte-depleted rhesus macaques.

Authors:  Lakshmanan Annamalai; Veena Bhaskar; Douglas R Pauley; Heather Knight; Kenneth Williams; Margaret Lentz; Eva Ratai; Susan V Westmoreland; R Gilberto González; Shawn P O'Neil
Journal:  Am J Pathol       Date:  2010-07-01       Impact factor: 4.307

Review 6.  Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders.

Authors:  Dionna W Williams; Mike Veenstra; Peter J Gaskill; Susan Morgello; Tina M Calderon; Joan W Berman
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

7.  Chronic Viral Neuroinflammation: Speculation on Underlying Mechanisms.

Authors:  Elizabeth C Delery; Andrew G MacLean
Journal:  Viral Immunol       Date:  2018-09-27       Impact factor: 2.257

8.  CD8+ T-cell responses against hemoglobin-beta prevent solid tumor growth.

Authors:  Hideo Komita; Xi Zhao; Jennifer L Taylor; Louis J Sparvero; Andrew A Amoscato; Sean Alber; Simon C Watkins; Angela D Pardee; Amy K Wesa; Walter J Storkus
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

9.  Loss of a tyrosine-dependent trafficking motif in the simian immunodeficiency virus envelope cytoplasmic tail spares mucosal CD4 cells but does not prevent disease progression.

Authors:  Matthew W Breed; Andrea P O Jordan; Pyone P Aye; Cornelis F Lichtveld; Cecily C Midkiff; Faith R Schiro; Beth S Haggarty; Chie Sugimoto; Xavier Alvarez; Netanya G Sandler; Daniel C Douek; Marcelo J Kuroda; Bapi Pahar; Michael Piatak; Jeffrey D Lifson; Brandon F Keele; James A Hoxie; Andrew A Lackner
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

Review 10.  Virus-host interaction in the simian immunodeficiency virus-infected brain.

Authors:  Howard S Fox
Journal:  J Neurovirol       Date:  2008-08       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.